Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs

Clinical Reviews in Allergy and Immunology

Volumn 24, Issue 2, 2003, Pages 137-147

  Berkes, Eva A ^a,b  

^a Sarasota Allerg/Asthma Specialty C   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

Anaphylactoid; Anaphylaxis; Aspirin; Cyclooxygenase; Non steroidal antiinflammatory drugs (NSAID)

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; DOLBID; ETODOLAC; FENOPROFEN CALCIUM; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMATE SODIUM; MEFENAMIC ACID; MELOXICAM; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ORUVAL; OXAPROZIN; PARACETAMOL; PIROXICAM; PYRAZOLONE DERIVATIVE; ROFECOXIB; SALSALATE; SULINDAC; TOLMETIN; UNINDEXED DRUG; ZOMEPIRAC;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BRONCHOSPASM; CROSS REACTION; DIARRHEA; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; FLUSHING; HUMAN; HYPOTENSION; NAUSEA; PREVALENCE; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIZATION; URTICARIA;

ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CROSS REACTIONS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PURPURA, SCHOENLEIN-HENOCH;

EID: 0037392928     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:24:2:137     Document Type: Review

References (44)

1. Jones, R. (2001), Nonsteroidal antiinflammatory drug prescribing: past, present and future. Am. J. Med. 110, 4S-7S.
2. Mengle-Gaw, L. J. S. B. Nonsteroidal antiinflammatory drugs, in Clinical Immunology: Principles and Practice, Rich, F. T. R. R., Shearer, W. T., Kotzin, B. L., and Schroeder, H. W., eds., Mosby, New York, 2001, pp. 107.1-107.10.
3. Stevenson, D. D. (2001), Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal antiinflammatory drugs. Immunology and Allergy Clinics of North America 21, 745-768.
4. Stevenson, D. (1998), Adverse reactions to nonsteroidal antiinflammatory drugs. N. American Clinics Allergy and Immunology 18:4, 773-798.
5. Stevenson, D., Sanchez-Borges, M., and Szczeklik, A. (2001), Classification of allergic and pseudo-allergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol. 87, 177-180.
6. DeJarnatt, A. C. G. J. (1992), Basic mechanism of anaphylaxis and anaphylactoid reactions. Immunology and Allergy Clinics of North America 12, 501-515.
7. Czerniawska-Mysik, G. and Szczeklik, A. (1981), Idiosyncrasy to pyrazolone drugs. Allergy 36, 381-384.
8. Krilis, S., Gregson, R. P., and Basten, A. (1981), Investigation of the possible involvement of IgE anti-salicylol antibodies in patients with urticaria. Int. Arch. Allergy Appl. Immunol. 64, 293-300.
9. Vidal, C. (1997), Parcetamol (acetaminophen) hypersensitivity. Annals of Allergy, Asthma and Immunology.
10. Szczeklik, A. (1986), Analgesics, allergy and asthma. Drugs 4, 148-163.
11. DeWeck, A. L. (1971), Immunologic effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int. Arch. Allergy 41, 393-400.
12. Phills, J. and Perelmutter, L. (1974), IgE mediated allergic type reactions to aspirin. Acta Allergol. 29, 474-490.
13. Daxun, Z., Becker, W. M., Schulz, K. H., and Schlaak, M. (1993), Sensitivity to aspirin: a new serologic diagnostic method. J. Investigational Allergol. Clin. Immunol. 3, 72-78.
14. Blanca, M., Perez, E., Garcia, J. J., Miranda, A., Terrados, S., Vega, J. M., et al. (1989), Angioedema and IgE antibodies to aspirin: a case report. Ann. Allergy 62, 295-298.
15. Quiralte, J., Blanco, C., Castillo, R., Ortega, N., and Carrillo, T. (1997), Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and crossreactivity studies. Ann. Allergy Asthma Immunol. 78, 293-296.
16. Van Diem, L. and Grilliat, J. P. (1990), Anaphylactic shock induced by parcetamol. Eur. J. Clin. Pharmacol. 38, 389-390.
17. Fernandez-Rivas, M., de la Hoz, B., and Cuevas, M. (1993), Hypersensitivity reactions to anthranilic acid derivatives. Ann. Allergy 71, 515-518.
18. Rake, G. W., Jr., and Jacobs, R. L. (1983), Anaphylactoid reactions to tolmetin and zomepirac. Ann. Allergy 50, 323-325.
19. Jett, G. K. and Wilson, E. (1984), Anaphylactic reaction associated with sulindac. Ann. Emerg. Med. 13, 462-464.
20. Strom, B. L., Carson, J. L., and Morse, M. L. (1987), The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other non steroidal antiinflammatory drugs. Arthritis Rheum. 30, 1142-1148.
21. Kemp, S. F., Lockey, R. F., Wolf, B. L., and Lieberman, P. (1995), Anaphylaxis: a review of 266 cases. Arch. Intern. Med. 155, 1749-1754.
22. Liberman, P. Anaphylaxis and anaphylactoid reactions, in Allergy: Principles and Practice, Middleton, E. J., Reed, C. E., Ellis, E. F., Adkinson, N. F., Jr., Yunginger, J. W., and Busse, W. W., eds., vol. 2, 5th ed. Mosby, St. Louis, 1998, pp. 1079-1092.
23. Szczeklik, A. and Stevenson, D. D. (1999), Aspirin-induced asthma: advances in pathogenesis and management. J. Allergy Clin. Immunol. 104, 5-13.
24. Hayllar, J. and Bjarnason, I. (1995), NSAIDs, Cox-2 inhibitors, and the gut. Lancet 346, 521-522.
25. Stevenson, D. D. (1993), Challenge procedures in detection of reactions to aspirin and nonsteroidal antiinflammatory drugs [editorial; comment]. Ann. Allergy 71, 417-418.
26. Bosso, J. V., Schwartz, L. B., and Stevenson, D. D. (1991), Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88, 830-837.
27. Stevenson, D. D., Arroyave, C. M., Bhat, K. N., and Tan, E. M. (1976), Oral aspirin challenges in asthmatic patients: a study of plasma histamine. Clin. Allergy 6, 493-505.
28. Sladek, K. and Szczeklik, A. (1993), Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur. Respir. J. 6, 391-399.
29. Stevenson, D. D. (1988), Oral challenges to detect aspirin and sulfite sensitivity in asthma. NE and Regional Allergy Proceedings 9, 135-142.
30. Ferreri, N. R., Howland, W. C., Stevenson, D. D., and Spiegelberg, H. L. (1988), Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am. Rev. Resp. Dis. 137, 847-854.
31. Anderson, J. A. (1992), Allergic reactions to drugs and biological agents. JAMA 268(20), 2844-2857.
32. Strom, B. L., Carson, J. L., and Schinnar, R. (1988), The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium versus other nonsteroidal antiinflammatory drugs. J. Rheumatol. 15, 695-699.
33. Van der Klauw, M. M., Stricker, B. H., and Herings, R. M. (1993), A population based case-cohort study of drug-induced anaphylaxis. Br. J. Clin. Pharmacol. 35, 400-408.
34. Scala, E., Giani, M., Pirrotta, L., Guerra, E. C., Locanto, M., De Pita, O., et al. (2001), Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal antiinflammatory drug intolerance. J. Allergy Clin. Immunol. 107, 557.
35. Levy, M. B. and Fink, J. N. (2001), Anaphylaxis to celecoxib. Ann. Allergy Asthma Immunol. 87, 72-73.
36. Rossi, A. C. K. D. (1982), Tolmetin-induced anaphylactoid reactions. N. Engl. J. Med. 307(8), 499-500.
37. Van Puijenbroek, E. P. E. A., Meyboom, R. H., and Leufkens, H. G. (2002), Different risks for NSAID-induced anaphylaxis. Ann. Pharmacother. 36(1), 24-29.
38. Szczeklik, A., Gryglewski, R. J., and Czerniawska-Mysik, G. (1977), Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J. Allergy Clin. Immunol. 60(5), 276-284.
39. Settipane, R. A., Shrank, P. J., Simon, R. A., Mathison, D. A., Christensen, S. C., and Stevenson, D. D. (1995), Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J. Allergy Clin. Immunol. 96, 480-485.
40. Stevenson, D. D., Hougham, A., Schrank, P., Goldlust, B., and Wilson, R. (1990), Disalcid cross-sensitivity in aspirin sensitive asthmatics. J. Allergy Clin. Immunol. 86, 749-758.
41. Stevenson, D. and Simon, R. A. (2001), Lack of crossreactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J. Allergy Clin. Immunol. 108, 47-51.
42. Dahlen, B., Szczeklik, A., and Murray, J. J. (2001), Celecoxib in patients with asthma and aspirin intolerance. N. Engl. J. Med. 344, 142.
43. Schellenberg, R. and Isserow, S. H. (2001), Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor. N. Engl. J. Med. 345, 1856.
44. Vane, J. R. (2000), The fight against rheumatism: from willow bark to COX-1 sparing drugs. J. Physiol. Pharmacol. 51(4 Pt 1), 573-586.